In AD, BBB dysfunction is increasingly recognized as a major early pathogenic mechanism, associated with APOE4 status, pericyte degeneration, reduced Aβ clearance, and altered glymphatic drainage [83]. The gene discussed is APOE; the disease is Alzheimer disease.